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0929-6441/ª 2014, Elsevier Taiwan LLAbstract Head and neck tumor is frequently encountered clinically, but the list of differen-
tial diagnosis of neck lumps is lengthy. Consequently, the major concern of diagnostic proce-
dure is to effectively narrow the possibility, and finally make an accurate diagnosis.
Ultrasound-guided core biopsy (USCB) has been well established in many medical fields as
the standard tissue sampling procedure, with less harm than open biopsy (OB) and more path-
ological information than ultrasound-guided fine needle aspiration (USFNA). In addition, using
the small-cutting needle, USCB can be easily and safely performed for head and neck lesions.
In this review, we present our optimal procedure of applying USCB and review its roles in head
and neck, including cervical lymph nodes, thyroid tumors, salivary tumors, pediatric head and
neck lesions, cervical infectious diseases, head and neck cancer and aerodigestive tumors. The
procedure-related bleeding and tumor seeding are rarely reported even after 7-year follow up
in the literature. The head and neck surgeons are competent to take care of any unpredictable
complications caused by USCB. According to our experience, USCB can be utilized as a power-
ful tool in surgeon’s hands to explore the possibilities of doing tissue sampling in many areas of
head and neck.
ª 2014, Elsevier Taiwan LLC and the Chinese Taipei Society of Ultrasound in Medicine.
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Fig. 1 Procedures of ultrasound-guided core biopsy. The
probe is in the surgeon’s left hand and the core needle is in the
right hand. The target lesion is harvested under ultrasound
guidance using the free hand method.
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Head and neck tumor is frequently encountered clinically,
and a complete evaluation of head and neck fields is the
first step to make the differential diagnosis. To make the
definite diagnoses of head and neck tumors, numerous
disease entities should be differentiated, including
congenital anomalies, infectious and inflammatory dis-
eases, and neoplastic lesions [1]. The origins of cervical
tumors include lymph node, major salivary glands, thyroid,
neurogenic tumor, vascular tumor, congenital cyst, ac-
quired abscess, or hematoma. Because of the lengthy list of
differential diagnoses of neck lumps, the major role of
diagnostic procedures is to effectively narrow the possi-
bility, and finally make an accurate diagnosis. Tissue sam-
pling is regarded as the standard procedure to make the
final diagnosis.
Conventionally, the standard tissue sampling methods of
head and neck tumors include open biopsy (OB) and
ultrasound-guided fine needle aspiration (USFNA). OB al-
ways provides sufficient specimens that help make the final
pathological diagnosis. However, creation of a surgical
wound and anesthesia are required for OB procedures. It is
especially not favorable for women because esthetic
outcome is always cause for concern. In addition, OB is
contraindicated for infirm patients who cannot tolerate
general anesthesia. USFNA can precisely harvest cells from
the target lesions with only a small needle puncture wound.
Because only cells are harvested for evaluation, the spec-
imen read by an experienced cytopathologist is important
for obtaining the correct diagnosis. Though immediate on-
site interpretation of USFNA results can improve diagnostic
accuracy by reducing inadequate sampling, it is expensive
and not affordable by many health care systems [2].
The application of ultrasound-guided core biopsy (USCB)
in head and neck lesions has recently drawn much atten-
tion. In addition to having a high diagnostic rate, USCB can
reduce the need for general anesthesia and improve
esthetic outcome [3,4].
Selection of the best diagnostic tool among OB, USFNA,
or USCB for head and neck tumor depends on the pros and
cons of each method. In cases with head and neck tumors
that are contraindicated for OB, USCB is a better diagnostic
tool than FNA because it provides pathological evidence.
For parotid gland tumors as examples, OB is not suggested
for tissue harvest because of a high risk of facial nerve
injury and tumor seeding. Consequently, FNA and USCB are
the diagnostic methods of choice for parotid gland tumors.
A report based on an 11-year experience showed the non-
diagnostic rate of USCB in the parotid gland was zero and
that of FNAC was 33% [3]. In cases other than parotid gland
tumors, the nondiagnostic rates of USCB, FNA, and OB were
3%, 44%, and zero, respectively [3].
Development of USCB
The needle biopsy technique was first available in 1982.
Tissue biopsies could therefore be performed by one
examiner under real-time ultrasound guidance [5]. USCB
currently is well established in many medical fields as the
standard tissue sampling procedure [5e11]. In solid organssuch as breast lesions, USCB demonstrates diagnostic ac-
curacy similar to that of OB, but with a lower complication
rate [10]. It also bears minimal risk of tumor spreading in
renal tumor diagnosis [9]. A systematic review proves the
role of USCB in pediatric tumors, which was associated with
a 94% biopsy adequacy rate, 94% diagnostic adequacy rate,
and 1% complication rate [8]. USCB had also been used to
diagnose thyroid nodules, with 87% adequacy and zero
false-negative rates [11]. It was concluded that USCB is an
accurate and safe alternative to USFNA in the assessment of
thyroid nodules. For the head and neck, USCB has been
used in the diagnosis of many diseases. For example, USCB
for diagnosing superficial lymphadenopathy, especially in
the neck and axilla, was first developed in Taiwan. Other
disease entities, including metastasis of malignancy, lym-
phoma, tuberculosis, Kikuchi-Fujimoto disease, and benign
lymphoid hyperplasia has also been diagnosed by USCB [6].
Optimizing the procedure of applying USCB for
head and neck tumors
Though it is possible to apply USCB techniques in head and
neck regions, the procedure routinely used in other medical
fields certainly is not useful for diagnosing head and neck
tumors. The 12e16-gauge cutting needles, which are
frequently used in USCB, are originally designed for breast
and abdominal lesions. They had been used for diagnosing
head and neck lesions [12]. It is believed that large-gauge
needles are associated with an increased possibility of
procedure-related complications, such as bleeding, wound
dehiscence, anesthetic requirement, and tumor seeding
potential [13]. The head and neck is a restricted anatomical
space with many complex and delicate structures. Diag-
nostic intervention should be less invasive to prevent any
related morbidity. Therefore, using cutting needles with
large gauges is clinically impractical for head and neck
tumors. We attempted to optimize the USCB procedure for
head and neck tumors [14]. Using the small cutting needle,
Fig. 2 (A) The inner needle was put forward when the outer needle was in the tumor. (B) The notch could be seen under ul-
trasound guidance, as the region indicated by the arrow. (C) The needle was triggered and the specimen was harvested. (D) The
outer needle cut the tissue and closed the notch, as seen by the status of the needle.
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addition, the current progress made in ultrasound resolu-
tion helps improve imaging quality during USCB for head
and neck tumors. Currently, USCB is one of the standard
diagnostic tools for head and neck tumors in many medical
institutions.Procedures of USCB in head and neck tumor
The patient was placed in a supine position with the neck
hyperextended. The neck skin was disinfected and draped
following the standard antiseptic procedure. A panoramic
ultrasound examination of the head and neck was first
performed with a 12 MHz linear probe. Sonographic fea-
tures and the location of targeted lesions were evaluated. A
color-duplex model was used to mark vasculature to avoid
vascular injury during the procedure. After the safest path
to the target tumor was identified, local anesthesia (0.001%
epinephrine þ 2% lidocaine solution) was injected subcu-
taneously around the area of the needle puncture. Under
ultrasound guidance, an 18-gauge biopsy needle (Temno
Evolution Biopsy Devices, Cardinal Health Inc., Dublin, Ohio
USA) was inserted without skin incision for sampling
(Fig. 1). Two notch sizes (10 mm or 20 mm) could be
selected depending on the size and the anatomical location
of the tumor. After tissue harvesting, the specimen was
removed from the needle notch, checked for quality and
quantity, and fixed in formalin solution (Fig. 2). One tissue
sample was collected. If the tissue quality and quantity was
not good enough in gross examination, a second sample was
obtained. All samples were sent to the pathology depart-
ment for staining and microscopic examination. After theprocedure, oozing from the puncture wound was controlled
with pressure for 5 minutes. The patient was observed for
30 minutes. If there were no signs of complications, the
patient was then discharged. The applications of USCB in
the head and neck are summarized in Table 1.
USCB for cervical lymph nodes
Using USCB to diagnose cervical lymphadenopathy was first
reported 1 decade ago [6]. To differentiate benign from
malignant lymphadenopathy, USCB was reported to have
high sensitivity (98.1%), specificity (100%), and accuracy
(98.7%). However, USCB also had high sensitivity, speci-
ficity, and accuracy in differentiating lymphoma from
reactive lymphadenopathy [15]. In a prospective study
using USCB with 18- or 20-gauge needles, only 17% patients
in whom lymphoma was diagnosed needed additional OB to
obtain more subtyping information for treatment [16].
Recent literature has also proved the applications of USCB
in confirming malignant lymphoma [17,18] and metastatic
cervical lymph nodes [3]. Accordingly, using USCB for
diagnosing cervical lymph nodes provides similar patholog-
ical information as OB, but only creates a wound as small as
USFNA, even for diagnosing lymphoma. In benign lymphoid
hyperplasia or self-limited disease such as Kikuchi-Fujimoto
disease, USCB can prevent unnecessary invasive diagnostic
procedures by surgical intervention [19].
USCB for thyroid tumors
The USFNA is regarded as the first-line diagnostic tool for
thyroid nodules. However, inadequate specimens and
Table 1 Summary of ultrasound-guided core biopsy in head and neck applications.
Indications Advantages of ultrasound-guided core biopsy References
Cervical lymph
nodes
Ultrasound-guided core biopsy has high sensitivity, specificity, and accuracy in
differentiating benign from malignant lymphadenopathy and lymphoma from
reactive lymphadenopathy.
[3,6,15e18]
Thyroid tumors When compared with ultrasound-guided fine needle aspiration, higher adequacy,
lower false-negative rate, and fewer patients who needed further surgical
confirmation could be achieved by ultrasound-guided core biopsy in thyroid lesions
without major complication. The combination of ultrasound-guided fine needle
aspiration with ultrasound-guided core biopsy may improve adequacy and sensitivity
of diagnosing thyroid lesions. Not all thyroid nodules are suitable for ultrasound-guided
core biopsy, so patient selection should be done judiciously.
[11,21e26]
Salivary tumors Ultrasound-guided core biopsy in salivary tumors, including parotid and submandibular
glands, has high diagnostic accuracy and confirms specific diagnoses. No case showed
tumor seeding after a 7-year follow up.
[24,27e30]
Pediatric head and
neck lesions
A variety of diagnoses can be confirmed solely by ultrasound-guided core biopsy,
avoiding further invasive biopsy procedures in pediatric patients. Ultrasound-guided
core biopsy showed high biopsy and diagnostic adequacy rate, and low complication
rate.
[8,31]
Cervical infectious
disease
Ultrasound-guided core biopsy can be used as the first-line diagnostic procedure for
suspected extrapulmonary tuberculosis.
[32]
Head and neck
cancer
Ultrasound-guided core biopsy can be performed in the outpatient clinics for
immediate tissue sampling, even without on-site cytologists. Ultrasound-guided
core biopsy also provides a simple and fast tissue sampling method to get early
diagnoses in the nonsurgical or palliative settings,
[12,15,33e35]
Aerodigestive
tumors
Ultrasound-guided core biopsy is helpful for tissue sampling in patients who were
not surgical candidates or failed to be diagnosed with hypopharyngeal cancer by
conventional endoscopic approaches.
[42,44,45,48]
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tered during USFNA [20]. When compared with USFNA,
higher adequacy (87%), lower false-negative rate (zero),
and fewer patients who required further surgical confir-
mation (11%) could be achieved by USCB in thyroid lesions.
USCB also minimized the nondiagnostic results of calcified
thyroid nodules that used to be confirmed by OB [21]. In
addition, no major complications were noted using USCB for
thyroid lesions [11]. Although the adequate rate of USCB
was significantly higher than that of USFNA (70.3%), not all
thyroid nodules are suitable for USCB. It has been reported
that USCB had less sensitivity in diagnosing papillary car-
cinoma [22]. The combination of USFNA with USCB may
improve adequacy and sensitivity of diagnosing thyroid le-
sions [22]. The single-shot technique of thyroid lesions that
permitted the rapid acquisition of tissue samples by both
USFNA and USCB facilitated diagnostic yields [23]. In addi-
tion, USCB has an important role in confirming thyroid
lymphoma, and the cases of indeterminate thyroid nodules
sampled by repeated USFNA [24,25].
Although USCB may provide more information on thyroid
lesions than USFNA, a higher complication rate was also
found in USCB, including hematoma and infection [26]. For
thyroid lesions, the addition of USCB to USFNA confers little
benefit in decreasing the nondiagnostic rates and may be
associated with increased complications. Therefore, some
reports suggested that USCB should not be routinely per-
formed in the evaluation of thyroid nodules. For USCB,
patient selection should be done judiciously [26].USCB for salivary tumors
To harvest tissue from parotid gland tumors, OB is not
routinely suggested because of a high risk of facial nerve
injury. The diagnostic accuracy of USCB for salivary tumors,
including those of the parotid and submandibular glands, is
reportedly high [27]. In addition, USCB also provided higher
sensitivity than USFNA in differentiating benign from ma-
lignant lesions of the parotid gland [28]. More specific di-
agnoses could also be confirmed by USCB, including
pleomorphic adenoma, Warthin tumor, and lymphoma
[29,30]. Regarding the potential of procedure-related
tumor seeding of USCB, only two cases of salivary tumor
seeding were reported after literature review. For these
two cases, USCB was performed with larger gauge needles
(14e16 gauge) [13]. For small-caliber needles (18e20
gauge), the incidence has never been reported. There was
no case showing tumor seeding after a 7-year follow up in a
systematic review [24].
USCB for pediatric head and neck lesions
The first application of USCB in pediatric tumors demon-
strated good tolerance under local anesthesia [31]. A vari-
ety of diagnoses were confirmed solely by USCB, including
Hodgkin disease, T-cell lymphoma, parotid hemangioma,
and granulomatous inflammation [31]. These diagnoses
confirmed by USCB prevent additional invasive biopsy
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also validated the role of USCB in pediatric tumors, showing
a 94% biopsy adequacy rate, 94% diagnostic adequacy rate,
and 1% complication rate [8].
USCB for cervical infectious diseases
Most patientswith extrapulmonary tuberculosis presentwith
cervical lymphadenopathy. USFNA is themost common initial
diagnostic procedure, but sensitivity is low. OB is regarded as
the gold standard for pathological confirmation, but com-
plications such as infection, scarring, nerve injury, and
longer-term discharge sinus frequently occur. Using USCB,
the sensitivity (95%) is equivalent to that of OB (91%).
Consequently, USCB can be used as the first-line diagnostic
procedure for suspected extrapulmonary tuberculosis [32].
USCB for head and neck cancer
In head and neck cancer, USCB is a safe and efficient tool
for tissue harvest [12]. When guided by ultrasound, USCB
could be easily performed in the outpatient clinic for im-
mediate tissue sampling [15]. In order to set “one stop”
clinics in the investigation and diagnosis of head and neck
tumors, the National Institute for Clinical Excellence (NICE)
guidelines in the United Kingdom recommend ultrasound-
guided tissue sampling methods. When compared with
FNA, USCB with small-bore needles (18- or 20-gauge) has
the advantages of higher accuracy, good tolerance, and
minimal invasiveness, even without on-site cytologists [33].
Its role as a complementary procedure had been adopted
by nonsurgical candidates or after repeated FNA failure
[34]. In the nonsurgical or palliative settings, USCB provides
a simple and fast tissue sampling method to obtain early
diagnoses [35]. For example, for those patients who
received radiotherapy as the primary treatment, USCB can
used to confirm the diagnosis without surgical intervention.
For occult lymph node metastasis and locoregional recur-
rence, ultrasound can be used for screening. When com-
bined with core biopsy, USCB facilitates early detection of
recurrence during follow-up.
USCB for aerodigestive tumors
Aerodigestive tumors such as tongue base [36], supraglottic
cancer [37], and hypopharyngeal tumors [38,39] potentially
can be visualized by transcutaneous ultrasound. Hypo-
pharyngeal cancer remains a clinical challenge among head
and neck malignancies because of its poor prognosis [40].
Clinically, microlaryngosurgery is regarded as the standard
procedure for diagnosing oropharyngeal and hypophar-
yngeal cancer. Microlaryngosurgery routinely serves as a
sampling method to harvest tissue for pathological exami-
nation [41,42]. Unfortunately, many patients with hypo-
pharyngeal cancer in an endemic area of betel nut chewing,
such as Taiwan, often simultaneously have trismus and
limited neck extension, which makes the rigid laryngoscopy
procedure difficult [43]. In elusive hypopharyngeal cancer
presenting with submucosal extension and intact mucosa, it
is sometimes difficult to identify the location and delineatethe extension of tumors by direct vision through a laryn-
goscope. Flexible endoscopy is performed without general
anesthesia; therefore, it serves as an alternative for rigid
laryngoscopy. However, because of the small size of flexible
endoscopic biopsy instruments, harvesting of a deep-seated
tumor is difficult [43].
Ultrasonography allows for a comprehensive evaluation
of the depth of soft-tissue extension of tumors and real-
time monitoring of the biopsy procedure. Ultrasonography
is an office-based procedure with a low medical cost.
General anesthesia is not required, and the duration is
short. Because of these advantages, USCB can overcome
the drawbacks noted in the aforementioned sampling pro-
cedures. Although the hypopharynx has been proved to be
visible and evaluable by ultrasound, only a limited number
of studies have attempted core biopsy to harvest tumor
specimens [42,44]. The role of USCB in hypopharyngeal
cancer was first reported by us showing the feasibility of
using USCB for tissue sampling in patients who were not
surgical candidates or who did not receive a diagnosis of
hypopharyngeal cancer by conventional endoscopic ap-
proaches [45,46].
Potential complications of applying USCB in the
head and neck
The potential complications of applying USCB for head and
neck tumors are bleeding and tumor seeding. Coupled with
Doppler mode, ultrasound guidance can help identify the
vascular tumor and avoid major vessels during the proce-
dure. The incidence of bleeding is 1%, and most tumors are
mild hematomas without major bleeding [24]. No mortality
by USCB has ever been reported.
Tumor seeding after transcutaneous cutting needle bi-
opsy in the head and neck was rarely reported [47]. Ac-
cording to the literature, using smaller needles for USCB
never showed tumor seeding, even after a 7-year follow-up
[24,29].
Selection of the gauge size of the core needle
For lymphoma diagnosis, a large needle size increases
diagnostic yields. The 14-gauge needles confirmed 100% of
cases with lymphoma, and only 11% required further biopsy
for subtyping [17]. The 18-gauge needles confirmed only
83% lymphoma diagnoses, and 18% needed further biopsy
for subtyping [17]. However, most studies using 18e20-
gauge needles for head and neck tumors provided accept-
able pathological information, but with few complications
[3,28,29,48].
Therefore, as the first-line diagnostic tool or comple-
mentary role to USFNA, USCB with a small-caliber needle
can provide diagnostic accuracy with minimal invasiveness
[14].
Who performs the USCB?
The blind FNA guided by hand palpation had served as a
standard procedure for head and neck tumors, and can be
performed by most physicians clinically. However, the
138 C.-N. Chen, T.-L. Yangultrasound-guided invasive procedures were mostly per-
formed by specialists. Ultrasound guidance is an extension
of the physical examination, especially for the deep-seated
masses [49]. It had been reported that USFNA yielded a
higher diagnostic rate in comparison with standard palpa-
tion technique [50]. Because they are familiar with the
anatomy of the head and neck, head and neck surgeons can
harvest the target lesion by themselves to avoid commu-
nication errors between clinical doctors and radiologists.
The head and neck surgeons have the competence to take
care of any unpredictable complications caused by USCB.
According to our experience, USCB can be used as a
powerful tool by surgeons to explore the possibility of tis-
sue sampling in many areas of the head and neck, such as
the tongue base, supraglottis, parapharynx, hypopharynx,
and larynx.
Conclusion
Head and neck tumors are common. The use of simple,
convenient, safe, rapid, and minimally invasive procedure
to obtain enough tissue samples for making the accurate
diagnosis is always appealing. Assisted by advanced ultra-
sonography and biopsy instruments, USCB is suggested as
one of the important diagnostic tools for head and neck
tumors.
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